Bioxyne Limited (AU:BXN) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Bioxyne Limited has announced a change in director Anthony Ho’s interests, with the acquisition of 5 million unlisted options approved by shareholders. The options have an exercise price of $0.02 and expire in December 2027. This change aligns with the company’s strategic decisions and reflects shareholder support.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.